BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 29330755)

  • 1. [Lymphoma in rheumatic diseases].
    Rubbert-Roth A; Bittenbring JT; Assmann G
    Z Rheumatol; 2017 Oct; 76(Suppl 2):46-56. PubMed ID: 29330755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
    Zintzaras E; Voulgarelis M; Moutsopoulos HM
    Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
    Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
    Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suspected inflammatory rheumatic diseases in patients presenting with skin rashes.
    Alves F; Gonçalo M
    Best Pract Res Clin Rheumatol; 2019 Aug; 33(4):101440. PubMed ID: 31585842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy in Rheumatic Diseases: Role in the Pathogenesis and Therapeutic Approaches.
    Celia AI; Colafrancesco S; Barbati C; Alessandri C; Conti F
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Sjögren's syndrome.
    Bowman SJ
    Lupus; 2018 Oct; 27(1_suppl):32-35. PubMed ID: 30452329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
    Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and dermatomyositis): a clinicopathologic study of 24 Japanese cases.
    Kojima M; Itoh H; Shimizu K; Saruki N; Murayama K; Higuchi K; Tamaki Y; Matsumoto M; Hirabayashi K; Igarishi S; Masawa N; Nakamura S
    Int J Surg Pathol; 2006 Jan; 14(1):43-8. PubMed ID: 16501834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
    Smedby KE; Baecklund E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosa-associated lymphoid tissue lymphomas in two patients with rheumatoid arthritis on second-line agents, and secondary Sjögren's syndrome.
    Sutcliffe N; Smith C; Speight PM; Isenberg DA
    Rheumatology (Oxford); 2000 Feb; 39(2):185-8. PubMed ID: 10725070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatic disease patients, prone to Sjögren's syndrome and/or lymphoma, mount an antibody response to BHRF1, the Epstein-Barr viral homologue of BCL-2.
    Newkirk MM; Shiroky JB; Johnson N; Danoff D; Isenberg DA; Shustik C; Pearson GR
    Br J Rheumatol; 1996 Nov; 35(11):1075-81. PubMed ID: 8948292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of systemic lupus erythematosus (SLE) to rheumatoid arthritis (RA), discoid lupus erythematosus (DLE) and Sjögren's syndrome. A clinical study.
    Bencze G
    Acta Rheumatol Scand; 1970; 16(3):191-6. PubMed ID: 5488864
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
    Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
    Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics of patients with rheumatic diseases and abnormal liver function].
    Wu CY; Li MC; Duan XW; Li HB; Wang YH; Li Q; Luo H; Xu J; Wu LJ; Wang YF; Zhao C; Fang YF; Lin SD; Xu D; Tian XP; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1102-1113. PubMed ID: 37650184
    [No Abstract]   [Full Text] [Related]  

  • 18. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A; Talal N
    Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases.
    Abrão AL; Santana CM; Bezerra AC; Amorim RF; Silva MB; Mota LM; Falcão DP
    Rev Bras Reumatol Engl Ed; 2016; 56(5):441-450. PubMed ID: 27692394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.